 |
 |
 |
| Home | Admin Office | Retail Outlets | Stores | Order Forms | Suggestion | BMI | Career |
|
||||||||
|
| Company |
 | ALPHARMA | ||
| Alpharma was founded in 1903 in Kristiania (Oslo) in Norway under the name Apothekernes laboratorium (A.L) to develop and manufacture pharmaceuticals in an industrial setting. The real start for the company was in 1954 by manufacturing Bacitracin and zinc Bacitracin for topical formulations. By the 1970’s the company became world’s largest manufacturer of Bacitracin. In 1983 the Danish company Dumex was acquisized by Alpharma. The name has been changed from A.L Industrier to Alpharma inc. in 1994. And Alpharma now is one of the leading generics pharmaceutical companys world wide. More details about the company and its products can be requested by calling the Administrative office at +974 4320887/909/919 | |||
 | SPIMACO | ||
| Saudi Pharmaceutical Industries & Medical Appliances Corporation (SPIMACO) is a Saudi Joint–Stock company with a fully paid-up capital of SR 600 million. It was established in 1986 with the main objective of setting up an advanced pharmaceutical industry in the Kingdom of Saudi Arabia , for the local production of medicines and medical appliances and to market these products inside the Kingdom and for Export. SPIMACO has developed a strong position in Saudi Arabia and is well positioned to sustain its growth and have a sound platform to serve export markets. SPIMACO main manufacturing facility – Al–Qassim Pharmaceutical Plant was planned , constructed and equipped up to the highest quality levels. SPIMACO earned a lot of national quality awards and attained major international certifications. SPIMACO serves successfully several markets locally and internationally and have built superior relations with regulatory bodies and the medical professions at large. The heavy investments in regulatory, marketing, sales and international alliances gave SPIMACO the market capabilities to prosper and overtake a lot of competitors. An important and distinctive advantage of SPIMACO strategy is its relations with multinational companies. A very flexible, objective and versatile approach let to a multitude of relationships that served the interests of all parties. SPIMACO is a successful joint stock company and it has one of the most actively traded shares in the Saudi stock market. Its financial performance over 11 years of operation is a model picture envied by numerous public companies. | |||
 | PHARCO | ||
| Pharco pharmaceutical is an Egyptian shareholding company headquartered in Alexandria, Egypt. The company manufactures and markets more than 250 brand and generic products which almost cover all pharmacological drug groups and all conventional pharmaceutical dosage forms. The manufacturing process of the soft gelatine capsules is a unique model, as it is the only licensed facility in the Middle East & Africa by R. P. Scherrer- USA With customer focus in mind, Pharco is able to answer and anticipate its customer needs. By cultivating strong relationships with healthcare practices and professionals, Pharco has always sought to become a true partner in facing a world of constantly changing healthcare challenges. The continuous confidence and support provided by both patients and healthcare professionals have put Pharco on top of the list of pharmaceutical companies in Egypt, a fact testified by the annual unit sales which ranked Pharco as the second seller of pharmaceuticals in Egypt. In Qatar Pharco provides its customers and patients with products with value for money, this strategy has helped Pharco to become the market leader in many therapeutic groups. Some leading brands include. Fawar Fruit, Uricol Eff, Ulstop caps & Farcolin sy. For further information on PHARCO products,please contact Mr Yohan Fariz Ziard, Medical Representative, Pharco Pharmaceuticals on his mobile : +974 5373718 or by e-mail pharco@qatarpharmacyest.com or by calling Administrative office at +974 4320887/909/919. | |||
 | ORTIS | ||
 | FERRING | ||
| Ferring Pharmaceuticals is a research-driven biopharmaceutical company devoted to identifying, developing and marketing innovative products in the fields of urology, gynaecology & obstetrics, gastroenterology and endocrinology. The company’s research activities and products are connected by a common thread focused on the provision of tailored treatments that work on the body’s own terms to enable doctors combat numerous diseases and medical conditions. The company has gained international recognition over the last 20 years for the creation of inventive medications that improve the quality of life of children and adults all around the world. In recent years Ferring has expanded beyond its traditional European base. It now has offices in over 40 countries employing over 2,700 people, and its treatments are available in more than 70 countries. This expansion has allowed Ferring to maintain a double digit annual growth rate over the last two decades. FerringR17;s R&D projects complement Ferring’s product portfolio and will add a new generation of products to some of the company’s most successful specialty brands. Ferring is committed to a future where it will continue to provide new and innovative medicines by utilising existing and acquired skills and the development of pioneering technologies and, where necessary, through partnerships with academic institutes and other companies. For further information on any of FERRING products,please contact Mr.Shadi Saleh Medical Representative, Ferring Pharmaceuticals C/O: Qatar Pharmacy Est. P.O.Box: 390, Doha - Qatar. Office: +974-4320887 Fax: +974-4320933 Mobile: +974-5425657 | |||
 | PHARMACEUTICAL SOLUTION INDUSTRIES LTD. (PSI) | ||
| In the Industrial Estate of Jeddah, Saudi Arabia’s commercial capital lies one of the Kingdom’s biggest manufacturing enterprises pharmaceutical solution Industries (P.S.I.). In cooperation with Fresenius, the leading German company, P.S.I. is based on the most advanced technology to produce life-saving intravenous fluids, dialysis solutions and oral feeding solutions. The factory of P.S.I. was built in 1980, and the commercial production was started in September 1983. More details about the company and its products can be requested from the Medical Representative, DR SAMER AL OTAIBI by contacting him at psi@qatarpharmacyest.com or on his mobile phone : +974 5423074 or by calling the Administrative office at +974 4320887/919/909. | |||
 | SEDICO | ||
| Started way back in the year 1990,SEDICO has managed to stick along, very well. The company has stretched, elongated and diversified into newer therapeutic areas while consolidating the existing ones. And all the diversification has emerged the production of newer products to roll out from the factory. The products deal with some of the most vital parts of a human system. We will come to that later, meanwhile let’s get a feel of the more vital factors and make out as to what made this company a pretty well known pharmaceutical giant. History For all the gains and pains it can today proudly boast of being a ISO 9001 & ISO 14001 certified company. The battles and trials have been worth every piaster spent, they have turned into an ocean of excellence and satisfaction, with many a happy client. The production facility just seems to have got better and as to date the company can feel a tinge of pride to being one of the largest and most experienced contract manufacturer for a number of multinational companies naming Organon pharmaceuticals (akzo-nobel group), which on the other hand owns 24% of the company’s shares. SEDICO pharma, to put it very correctly is a pharmaceutical manufacturer, which possesses excellent facilities and state-of-the-art manufacturing equipment. The company has strategic alliances with several multinational companies; these strategic alliances have resulted in the spawning of state-of-the-art-facility for Bio-technology products, which includes Insulin, Epoietin, Angikinase, Sedonase etc For more information on SEDICO range of products,please contact the Medical Representative, Dr Fakhredin on his mobile : +974 5786797 or the Administrative office Tel: +974 4320887/919/909, Fax: +974 4320933. | |||
 | LEIRAS | ||
 | VITABIOTICS | ||
| VITABIOTICS Vitabiotics has manufactured innovative health care products for over 35 years; a British company committed to human and research. “Vitabiotics strives to respond sensitively to consumer needs, researching and developing scientifically proven, nutrient based healthcare solutions of a quality and efficacy for world healthcare markets”. Progress through the years • Vitabiotics is founded in London by Dr K.T.Lalvani and Dr H.Meyer, of Bonn University, launching the licensed mouth ulcer treatment Oralcer, with a British patent. • Developed Omega-H3®, the comprehensive multivitamin , now the No 1 selling around the world. • National launch of Premence® and Menopace® following success in independent UK clinical trials. • UK market data confirms Pregnacare®, Menopace®, Perfectil® and Osteocare® are all brand leaders in their fields. • Vitabiotics’ market activity extends to over 80 countries worldwide. • Vitabiotics enters the US market and strengthens web presence with launch of e-commerce site. What makes Vitabiotics’ products successful? • Vitabiotics’ products are developed by a team of highly qualified pharmacists, and medical consultants in conjunction with UK universities * The University of Oxford The role of micro-nutrient supplementation during the menopause (Menopace®). * Glasgow Caledonian University Department of Vision Science The effect of antioxidant supplementation on eye tear film stability and Conjunctively health (Visionace®). * The University of North London, the Institute of Brain Chemistry and Human Nutrition ‘The Preconception Intervention Programme’ (Pregnacare®). * University of Reading The MIDI (Micronutrients and Diabetes) study (Diabetone®). • Ingredient in formulations carefully balanced to maximize their combined effect. • Formulations updated and improved on basis of the latest research. • Products shown to be highly effective during independent clinical trials. • Free from artificial colors, gluten, fat, salt and yeast. World class pharmaceutical control Every Vitabiotics product is high pharmaceutical standards of quality control. Manufacture is fully licensed according to Good Manufacturing Practice (GMP) under conditions approved bay relevant authorities such as the MCA, FDA and according to exacting standard such as ISO 29 002 . Our mission Innovation is the key to Vitabiotics’ success. This means keeping at leading edge of international research on the one hand, wile remaining sensitive to specific consumer needs on the other. Vitabiotics has a profound commitment to translating the latest scientific advancements into effective products, which are fully integrated with modern consumer lifestyles. “Vitabiotics guarantees the highest technological skills and a dedication to excellence”. For futher information,please contact: Dr A.TAHAN Medical representative, Vitabiotics Qatar Pharmacy establishment e-mail:vitabiotics@qatarpharmacyest.com or Mobile: +974 5901680 or at +974 4320887/909/919(Administratve office) | |||
 | YANASE WAITCH | ||
| 1 | 2 | 3 |